 |
all-cis-docosa-4,7,10,13,16,19-hexaenoic acid |
|---|---|
| Trade Name | Retriacyl |
| Orphan Indication | Retinitis pigmentosa |
| USA Market Approval | USA |
| USA Designation Date | 2014-05-21 00:00:00 |
| Sponsor | Natac Pharma, S.L.;C/ Faraday 7, 28049;Madrid |
Related Access Program
| |
all-cis-docosa-4,7,10,13,16,19-hexaenoic acid |
|---|---|
| Trade Name | Retriacyl |
| Orphan Indication | Retinitis pigmentosa |
| USA Market Approval | USA |
| USA Designation Date | 2014-05-21 00:00:00 |
| Sponsor | Natac Pharma, S.L.;C/ Faraday 7, 28049;Madrid |